Cosmo Technologies Limited

bile acid diarrhoea

Research activity in bile acid diarrhoea focuses on treatments aimed at improving stool consistency and controlling symptoms linked to abnormal bile acid handling in the gut. The sponsor’s work in this area is centered on gastrointestinal symptom relief and functional bowel health.

  • gastrointestinal motility
  • stool consistency
  • bile acid malabsorption

The therapeutic interest extends to digestive disorders where restoring bowel function and reducing diarrhoeal burden are key clinical priorities.

ulcerative colitis

Clinical research in ulcerative colitis is directed toward patients with mild to moderate left-sided disease, with attention to achieving clinical remission and reducing inflammatory activity in the colon. This area reflects a focus on bowel inflammation and disease control in inflammatory bowel disease.

  • colonic inflammation
  • clinical remission
  • left-sided colitis

The sponsor’s interest includes local treatment approaches for distal colonic disease and symptom management in gastroenterology.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness and Safety of Colesevelam Hydrochloride for Patients with Idiopathic Bile Acid Diarrhea (BAD)

    Recruiting

    2 1
    Investigated drugs:
    Belgium Denmark Italy Romania Spain
  • Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Estonia Hungary Latvia Lithuania Poland +1